Company
Headquarters: Singapore, Singapore
Employees: 26
CEO: Mr. Tang Yih Song
S$9.2 Million
SGD as of Jan. 1, 2024
US$7.0 Million
| Company | Market Cap (USD) |
|---|---|
| Abbott | $192.67 B |
| Stryker Corporation | $113.24 B |
| Medtronic | $111.60 B |
| Boston Scientific Corporation | $85.22 B |
| Shenzhen Mindray Bio-Medical Electronics Co. Ltd | $49.33 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Biolidics Limited, a precision medicine medical technology company, focuses on developing a portfolio of diagnostic solutions. It operates through Cancer, Infectious Diseases, and Laboratory Services segments. The company engages in the research, experimental development, marketing, and distribution of biotechnology, life and medical science, and electronics related industrial design services. It offers ClearCell FX1 System, an automated in vitro diagnostic medical device that separates and enriches cancer cells from blood; and antigen and antibody test kits, as well as laboratory services. The company has a strategic collaboration with Sysmex Corporation. It serves academic and research institutes, hospitals, and laboratories in Singapore, China, Hong Kong, Japan, the United States, and other European Union countries. The company was incorporated in 2009 and is based in Singapore.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Biolidics Ltd has the following listings and related stock indices.
Stock: SGX: 8YY wb_incandescent